1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2015-2019 Europe Flow Cytometry Market: Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

2015-2019 Europe Flow Cytometry Market: Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

  • July 2015
  • -
  • Venture Planning Group
  • -
  • 270 pages

Summary

Table of Contents

This unique report contains 270 pages, 75 tables and provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.

This 5-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years.  The report explores future marketing and technological trends in five major European countries (France, Germany, Italy, Spain, and the UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of major clinical and research flow cytometers; profiles competitors and emerging market entrants; and suggests specific product and marketing opportunities for flow cytometry instruments and reagents.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the flow cytometry markets worldwide.  New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.  The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories.  Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features.  Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.                                                                                      

Contains 270 pages and 75 tables

This unique report contains 270 pages, 75 tables and provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.

This 5-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years.  The report explores future marketing and technological trends in five major European countries (France, Germany, Italy, Spain, and the UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of major clinical and research flow cytometers; profiles competitors and emerging market entrants; and suggests specific product and marketing opportunities for flow cytometry instruments and reagents.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the flow cytometry markets worldwide.  New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.  The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories.  Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features.  Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.                                                                                      

Contains 270 pages and 75 tables

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.